Skip to main content
. Author manuscript; available in PMC: 2009 Oct 14.
Published in final edited form as: Cancer Gene Ther. 2008 Apr 11;15(7):413–448. doi: 10.1038/cgt.2008.15

Table 3.

Protein SH2 or PTB domains interacting with pTyr sites in ERBB3 with high affinity (dissociation constants <1000 nm*, <500 nm**, <100 nm***)

Domain source pY868 pY1054 pY1197 pY1222 pY1260 pY1260–62 pY1276 pY1289 pY1328
PI3KR1 N * * ** * **
PI3KR1 C * ***
PI3KR1 NC ** ** ** *** * *** ***
PI3KR2 N * ** ** ** ** ***
PI3KR2 C *
PI3KR2 NC *** ** ** *** * *** ***
PI3KR3 N * ** * ** ** ***
PI3KR3 C ** ** ** ** ***
PI3KR3 NC *** * *** ** *** *** ***
ABL1 *
ABL2 *** ** ** ** ** *** *
RASA1N * * * * *
GRB7 *** * *
SYK NC * * *
HCK * **
PLCG1 C * **
PLCG1 NC * **
SHC1 * *
SHC3 * **
CRK **
NCK1 **
NCK2 *
CRKL **
JAK2 *
VAV2 **
VAV1 **
SRC *
TENS1 *
DAPP1 *
FER **
ITK **
LYN **
PTK6 **
TENC1 *
SHC1-PTB **

Data summarized from Jones et al.,133 Supplementary Table 4. Lower affinity interactions detected in the study may also be seen in this Table. For proteins with two SH2 domains, these were tested separately (N, C) or together (NC).